Drug Shortage Report for MYLAN-RIVASTIGMINE PATCH 10
Report ID | 83413 |
Drug Identification Number | 02423421 |
Brand name | MYLAN-RIVASTIGMINE PATCH 10 |
Common or Proper name | RIVASTIGMINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | RIVASTIGMINE |
Strength(s) | 18MG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL |
Packaging size | 30 PATCHES |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-06-04 |
Actual start date | 2019-06-04 |
Estimated end date | 2019-07-26 |
Actual end date | 2019-07-29 |
Shortage status | Resolved |
Updated date | 2019-07-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-05-08 | French | Compare |
v1 | 2019-05-08 | English | Compare |